Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von CandyButcher 

Merck & Co. Inc. diskutieren

Merck & Co. Inc.

WKN: A0YD8Q / Symbol: MRK / Name: Merck & Co / Aktie / Pharmazeutika / Large Cap /

127,20 €
-0,44 %

Einschätzung Buy
Rendite (%) 20,14 %
Kursziel 110,77
Veränderung
Endet am 12.02.26

Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $122.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 46,64 %
Kursziel 101,20
Veränderung
Endet am 17.04.26

Merck & Co., Inc. (NYSE: MRK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $115.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 46,68 %
Kursziel 108,59
Veränderung
Endet am 24.11.26

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $125.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 47,02 %
Kursziel 103,37
Veränderung
Endet am 02.12.26

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $92.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 50,31 %
Kursziel 102,22
Veränderung
Endet am 15.12.26

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Bank of America Corporation from $105.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 49,60 %
Kursziel 110,75
Veränderung
Endet am 18.12.26

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $130.00 price target on the stock, up previously from $82.00.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 37,23 %
Kursziel 111,10
Veränderung
Endet am 07.01.27

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at UBS Group AG from $105.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 27,76 %
Kursziel 114,17
Veränderung
Endet am 04.02.27

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Wells Fargo & Company from $125.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 23,32 %
Kursziel 118,75
Veränderung
Endet am 06.02.27

Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Guggenheim from $122.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Merck & Co., Inc. (NYSE:MRK) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 25,25 %
Kursziel 126,38
Veränderung
Endet am 13.02.27

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $150.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 23,08 %
Kursziel 119,08
Veränderung
Endet am 20.02.27

Merck & Co., Inc. (NYSE:MRK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $140.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 21,21 %
Kursziel 120,47
Veränderung
Endet am 25.02.27

Merck & Co., Inc. (MRK) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 27,76 %
Kursziel 130,05
Veränderung
Endet am 12.03.27

Merck & Co., Inc. (MRK) had its price target raised by Wells Fargo & Company from $135.00 to $150.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 24,28 %
Kursziel 123,30
Veränderung
Endet am 30.03.27

Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 22,61 %
Kursziel 117,19
Veränderung
Endet am 06.04.27

Merck & Co., Inc. (MRK) had its price target raised by JPMorgan Chase & Co. from $125.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 25,16 %
Kursziel 124,06
Veränderung
Endet am 13.04.27

Merck & Co., Inc. (MRK) had its price target raised by UBS Group AG from $130.00 to $145.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 20,17 %
Kursziel 121,43
Veränderung
Endet am 24.06.27

Merck & Co., Inc. (MRK) is now covered by CICC Research. They set an "outperform" rating and a $138.00 price target on the stock.
Ratings data for MRK provided by MarketBeat